Results 211 to 220 of about 258,661 (263)
Leukocyte Count Is Better than LDL-C as Predictor of Novel Carotid Atherosclerosis. [PDF]
BiomedicinesLi Y +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinica Chimica Acta, 2022
The gold standard for measuring LDL-C is impractical for routine use while direct measurements have numerous shortcomings. This study investigated the correlation of predictive equations with currently used enzymatic assays in populations where these have historically proven unreliable to determine whether equations may be used interchangeably.
Nicolene, Steyn +3 more
openaire +2 more sources
The gold standard for measuring LDL-C is impractical for routine use while direct measurements have numerous shortcomings. This study investigated the correlation of predictive equations with currently used enzymatic assays in populations where these have historically proven unreliable to determine whether equations may be used interchangeably.
Nicolene, Steyn +3 more
openaire +2 more sources
Current Opinion in Lipidology, 2015
The measurement that is termed 'LDL-cholesterol' (LDL-C) includes the cholesterol content of lipoprotein(a) [Lp(a)-C], which can contribute approximately 30-45% to measured LDL-C levels as a percentage of its mass. We review the implications of achieved very low LDL-C levels in patients treated with potent LDL-C-lowering agents in the context of ...
Calvin, Yeang +2 more
openaire +2 more sources
The measurement that is termed 'LDL-cholesterol' (LDL-C) includes the cholesterol content of lipoprotein(a) [Lp(a)-C], which can contribute approximately 30-45% to measured LDL-C levels as a percentage of its mass. We review the implications of achieved very low LDL-C levels in patients treated with potent LDL-C-lowering agents in the context of ...
Calvin, Yeang +2 more
openaire +2 more sources
2023
ที่มา : ในการลดระดับ LDL-cholesterol (LDL-C) ด้วยยาลดไขมันในกลุ่มยา statin ที่มีความแรงระดับสูง (high-intensity statin) มีการพิสูจน์แล้วว่าลดอุบัติการณ์เกิดโรคหัวใจและหลอดเลือดในกลุ่มผู้ป่วยกล้ามเนื้อหัวใจขาดเลือด แต่เนื่องจากการศึกษาก่อนหน้านี้พบว่าผู้ป่วยกล้ามเนื้อหัวใจขาดเลือดมีระดับ LDL-C ยังไม่ได้ตามเกณฑ์มาตรฐาน (LDL-C น้อยกว่า 70 มิลลิกรัมต่อเดซ ...
openaire +1 more source
ที่มา : ในการลดระดับ LDL-cholesterol (LDL-C) ด้วยยาลดไขมันในกลุ่มยา statin ที่มีความแรงระดับสูง (high-intensity statin) มีการพิสูจน์แล้วว่าลดอุบัติการณ์เกิดโรคหัวใจและหลอดเลือดในกลุ่มผู้ป่วยกล้ามเนื้อหัวใจขาดเลือด แต่เนื่องจากการศึกษาก่อนหน้านี้พบว่าผู้ป่วยกล้ามเนื้อหัวใจขาดเลือดมีระดับ LDL-C ยังไม่ได้ตามเกณฑ์มาตรฐาน (LDL-C น้อยกว่า 70 มิลลิกรัมต่อเดซ ...
openaire +1 more source
Current Medical Research and Opinion, 2009
This article reviewed the collective evidence from routine clinical practice to summarize the existing literature on the effectiveness of rosuvastatin in treating hypercholesterolemia.A comprehensive Medline literature search identified all published articles, in all languages, from January 2003 through September 2008 on the use of rosuvastatin in the ...
Sanjay K, Gandhi +3 more
openaire +2 more sources
This article reviewed the collective evidence from routine clinical practice to summarize the existing literature on the effectiveness of rosuvastatin in treating hypercholesterolemia.A comprehensive Medline literature search identified all published articles, in all languages, from January 2003 through September 2008 on the use of rosuvastatin in the ...
Sanjay K, Gandhi +3 more
openaire +2 more sources
Optimizing LDL-C Lowering With Statins
American Journal of Therapeutics, 2004Clinical studies have demonstrated the efficacy of statins in reducing low-density lipoprotein cholesterol (LDL-C) and lowering coronary heart disease risk. However, many patients receiving statin therapy in clinical practice are not achieving their LDL-C goals.
openaire +2 more sources
Current Pharmaceutical Design, 2019
Background: Low-density Lipoprotein Cholesterol (LDL-C) is a major Cardiovascular (CV) risk factor. Accumulating evidence supports a linear association between LDL-C levels and CV risk. However, the lower limit of LDL-C that might offer CV benefits without any safety concerns is still a topic of debate.
Charles, Faselis +5 more
openaire +2 more sources
Background: Low-density Lipoprotein Cholesterol (LDL-C) is a major Cardiovascular (CV) risk factor. Accumulating evidence supports a linear association between LDL-C levels and CV risk. However, the lower limit of LDL-C that might offer CV benefits without any safety concerns is still a topic of debate.
Charles, Faselis +5 more
openaire +2 more sources
Dietary Approaches to Lowering LDL-C
2021Multiple epidemiological, experimental, genetic, and interventional trials have unequivocally established that low-density lipoprotein (LDL) is a causal risk factor for the initiation and progression of atherosclerosis. LDL-cholesterol (LDL-C) is a key goal for primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD) according
Parag Anilkumar Chevli +1 more
openaire +1 more source
LDL-C-Senkung bei Dialysepatienten
Nephrologie aktuell, 2023ZUSAMMENFASSUNGPatienten, die aufgrund einer schweren Nierenerkrankung auf eine Dialyse angewiesen sind, haben ein hohes Risiko für Herz-Kreislauf-Erkrankungen. Häufig leiden diese Patienten u. a. auch an Bluthochdruck, Fettstoffwechselstörungen oder Diabetes mellitus.
openaire +1 more source